Skip to main content
Top
Published in: Diabetologia 3/2010

01-03-2010 | Short Communication

Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

Authors: J. Labad, J. F. Price, M. W. J. Strachan, F. G. R. Fowkes, J. Ding, I. J. Deary, A. J. Lee, B. M. Frier, J. R. Seckl, B. R. Walker, R. M. Reynolds, on behalf of the Edinburgh Type 2 Diabetes Study Investigators

Published in: Diabetologia | Issue 3/2010

Login to get access

Abstract

Aims/hypothesis

The aim of the study was to identify risk factors for depression and anxiety in a well-characterised cohort of individuals with type 2 diabetes mellitus.

Methods

We used baseline data from participants (n = 1,066, 48.7% women, aged 67.9 ± 4.2 years) from the Edinburgh Type 2 Diabetes Study. Symptoms of anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS). Obesity was characterised according to both overall (body mass index, fat mass) and abdominal (waist circumference) measurements. Cardiovascular disease was assessed by questionnaire, physical examination and review of medical records. Stepwise multiple linear regression was performed to identify explanatory variables related to either anxiety or depression HADS scores.

Results

Abdominal obesity (waist circumference) and cardiovascular disease (ischaemic heart disease and ankle–brachial pressure index) were related to depression but not anxiety. Lifetime history of severe hypoglycaemia was associated with anxiety. Other cardiovascular risk factors or microvascular complications were not related to either anxiety or depressive symptoms.

Conclusions/interpretation

Depression but not anxiety is associated with abdominal obesity and cardiovascular disease in people with type 2 diabetes mellitus. This knowledge may help to identify depressive symptoms among patients with type 2 diabetes who are at greatest risk.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T (2005) Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabet Med 22:293–300CrossRefPubMed Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T (2005) Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabet Med 22:293–300CrossRefPubMed
2.
go back to reference Adriaanse MC, Dekker JM, Heine RJ et al (2008) Symptoms of depression in people with impaired glucose metabolism or type 2 diabetes mellitus: the Hoorn Study. Diabet Med 25:843–849CrossRefPubMed Adriaanse MC, Dekker JM, Heine RJ et al (2008) Symptoms of depression in people with impaired glucose metabolism or type 2 diabetes mellitus: the Hoorn Study. Diabet Med 25:843–849CrossRefPubMed
3.
go back to reference Katon W, von Korff M, Ciechanowski P et al (2004) Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 27:914–920CrossRefPubMed Katon W, von Korff M, Ciechanowski P et al (2004) Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 27:914–920CrossRefPubMed
4.
go back to reference Bruce DG, Davis WA, Starkstein SE, Davis TM (2005) A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 48:2532–2539CrossRefPubMed Bruce DG, Davis WA, Starkstein SE, Davis TM (2005) A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 48:2532–2539CrossRefPubMed
5.
go back to reference Katon WJ, Rutter C, Simon G et al (2005) The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 28:2668–2672CrossRefPubMed Katon WJ, Rutter C, Simon G et al (2005) The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 28:2668–2672CrossRefPubMed
6.
go back to reference Kasen S, Cohen P, Chen H, Must A (2008) Obesity and psychopathology in women: a three decade prospective study. Int J Obes (Lond) 32:558–566CrossRef Kasen S, Cohen P, Chen H, Must A (2008) Obesity and psychopathology in women: a three decade prospective study. Int J Obes (Lond) 32:558–566CrossRef
7.
go back to reference Vogelzangs N, Kritchevsky SB, Beekman AT et al (2008) Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry 65:1386–1393CrossRefPubMed Vogelzangs N, Kritchevsky SB, Beekman AT et al (2008) Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry 65:1386–1393CrossRefPubMed
8.
go back to reference Skilton MR, Moulin P, Terra JL, Bonnet F (2007) Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry 62:1251–1257CrossRefPubMed Skilton MR, Moulin P, Terra JL, Bonnet F (2007) Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry 62:1251–1257CrossRefPubMed
9.
go back to reference Price JF, Reynolds RM, Mitchell RJ et al (2008) The Edinburgh Type 2 Diabetes Study: study protocol. BMC Endocr Disord 8:18CrossRefPubMed Price JF, Reynolds RM, Mitchell RJ et al (2008) The Edinburgh Type 2 Diabetes Study: study protocol. BMC Endocr Disord 8:18CrossRefPubMed
10.
go back to reference Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital anxiety and depression scale. An updated literature review. J Psychosom Res 52:69–77CrossRefPubMed Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital anxiety and depression scale. An updated literature review. J Psychosom Res 52:69–77CrossRefPubMed
Metadata
Title
Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study
Authors
J. Labad
J. F. Price
M. W. J. Strachan
F. G. R. Fowkes
J. Ding
I. J. Deary
A. J. Lee
B. M. Frier
J. R. Seckl
B. R. Walker
R. M. Reynolds
on behalf of the Edinburgh Type 2 Diabetes Study Investigators
Publication date
01-03-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 3/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1628-9

Other articles of this Issue 3/2010

Diabetologia 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.